ARCHIVES

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

CMS Issues Coverage Decision For Provenge in Prostate Cancer

July 29, 2011

President Asks $600 Million For NCI In ’75; Research Grants Would Get $19 Million Hike

February 8, 1974

Bill Planned To Okay Medicare/Medicaid Payment For 100% Of Outpatient Anticancer Drug Costs

February 16, 1979

20% of Women Do Not Believe Tailored Risk Assessments

August 30, 2013

CCOP Reviewers Briefed On Program Objective, Criteria

January 7, 1983

NCI News: Varmus: “We Are Shrinking Everything” To Keep Grant Numbers Level During Cuts

November 15, 2013